drug

palonosetron

1 story · latest Sep 17, 2026

Status: FDA approved Mar 2016 · NDA203050
Brand: Posfrea

Timeline

FDA clears three labeling supplements for palonosetron, letrozole, carbamazepine

Sep 17Weekly roundup, 3 itemscarbamazepine letrozole

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.